Aclarion, Inc. (ACON) 10-Year Financial Performance & Capital Metrics

ACON • • Industrial / General

HealthcareHealthcare ITMedical Imaging & DiagnosticsGeneral Medical Imaging Software

AboutAclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.Show more

Revenue $46K -39.4%
EBITDA -$5M -12.9%
Net Income -$7M -42.4%
EPS (Diluted) -7480.22 +90.6%
Gross Margin -183.81% -42675.2%
EBITDA Margin -11634.83% -86.1%
Operating Margin -12057.23% -86.5%
Net Margin -15293.78% -134.8%
ROE -5777.8% -781.1%
ROIC -
Debt/Equity -
Interest Coverage -10.30 -28.4%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y sales CAGR of 11.2%
✓Trading at only 0.0x book value

✗Weaknesses

✗Weak Piotroski F-Score: 2/9
✗Negative free cash flow
✗Weak momentum: RS Rating 7 (bottom 7%)
✗Shares diluted 100.0% in last year
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y11.2%

3Y-8.81%

TTM36.91%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-16.99%

EPS CAGR

10Y-

5Y-

3Y-

TTM92.19%

ROCE

10Y Avg-1818.65%

5Y Avg-1818.65%

3Y Avg-1818.65%

Latest-4555.07%

Peer Comparison

General Medical Imaging Software

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
GEHCGE HealthCare Technologies Inc.	37.59B	82.51	19.01	0.61%	10.95%	21.68%	4.12%	1.08
ACONAclarion, Inc.	4.22M	4.00	-0.00	-39.36%	-108.68%	-58.67%
ONMDOneMedNet Corporation	43.35M	0.85	-2.36	-37.02%	-411.11%

Profit & Loss

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	26.9K	48.65K	60.29K	60.44K	75.4K	45.72K
Revenue Growth %	-	0.81%	0.24%	0%	0.25%	-0.39%
Cost of Goods Sold+	63.18K	66.25K	69.17K	65.3K	75.73K	129.77K
COGS % of Revenue	2.35%	1.36%	1.15%	1.08%	1%	2.84%
Gross Profit+	-36.28K	-17.59K	-8.88K	-4.85K	-324	-84.04K
Gross Margin %	-1.35%	-0.36%	-0.15%	-0.08%	-0%	-1.84%
Gross Profit Growth %	-	0.52%	0.5%	0.45%	0.93%	-258.39%
Operating Expenses+	3.98M	4.46M	2.94M	5.56M	4.88M	5.43M
OpEx % of Revenue	147.86%	91.67%	48.83%	91.93%	64.66%	118.73%
Selling, General & Admin	2.24M	1.41M	2.16M	4.49M	4M	4.59M
SG&A % of Revenue	83.3%	28.93%	35.76%	74.26%	53.08%	100.28%
Research & Development	1.74M	1.05M	787.85K	1.07M	873.34K	888.77K
R&D % of Revenue	64.57%	21.63%	13.07%	17.67%	11.58%	19.44%
Other Operating Expenses	0	2M	0	0	0	-45.11K
Operating Income+	-4.01M	-4.48M	-2.95M	-5.56M	-4.88M	-5.51M
Operating Margin %	-149.21%	-92.03%	-48.98%	-92.01%	-64.66%	-120.57%
Operating Income Growth %	-	-0.12%	0.34%	-0.88%	0.12%	-0.13%
EBITDA+	-3.84M	-4.28M	-2.77M	-5.42M	-4.71M	-5.32M
EBITDA Margin %	-142.58%	-88%	-45.89%	-89.64%	-62.51%	-116.35%
EBITDA Growth %	-	-0.12%	0.35%	-0.96%	0.13%	-0.13%
D&A (Non-Cash Add-back)	178.21K	196.28K	186.39K	143.62K	162.67K	193.14K
EBIT	-4.01M	-4.48M	-4.47M	-5.56M	-4.3M	-6.46M
Net Interest Income+	-5K	-156.04K	-476.48K	-1.51M	-608.12K	-535.15K
Interest Income	0	15	0	2.51K	172	318
Interest Expense	5K	156.06K	476.48K	1.51M	608.29K	535.47K
Other Income/Expense	-5.96K	-157.79K	-2M	-1.51M	-35.39K	-1.48M
Pretax Income+	-4.02M	-4.64M	-4.95M	-7.07M	-4.91M	-6.99M
Pretax Margin %	-149.43%	-95.27%	-82.11%	-116.94%	-65.13%	-152.94%
Income Tax+	0	0	0	0	0	0
Effective Tax Rate %	1%	1%	1%	1%	1%	1%
Net Income+	-4.02M	-4.64M	-4.95M	-7.07M	-4.91M	-6.99M
Net Margin %	-149.43%	-95.27%	-82.11%	-116.94%	-65.13%	-152.94%
Net Income Growth %	-	-0.15%	-0.07%	-0.43%	0.31%	-0.42%
Net Income (Continuing)	-4.02M	-4.64M	-4.95M	-7.07M	-4.91M	-6.99M
Discontinued Operations	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0
EPS (Diluted)+	-97680.00	-110583.00	-120035.00	-177396.00	-79782.00	-7480.22
EPS Growth %	-	-0.13%	-0.09%	-0.48%	0.55%	0.91%
EPS (Basic)	-97680.00	-110583.00	-120035.00	-177396.00	-79782.00	-7480.22
Diluted Shares Outstanding	50	50	50	42	62	943
Basic Shares Outstanding	50	50	50	42	62	943
Dividend Payout Ratio	-	-	-	-	-	-

Balance Sheet

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	218.51K	97.13K	732.2K	1.7M	1.29M	824.28K
Cash & Short-Term Investments	128.16K	14.98K	432.53K	1.47M	1.02M	453.66K
Cash Only	128.16K	14.98K	432.53K	1.47M	1.02M	453.66K
Short-Term Investments	0	0	0	0	0	0
Accounts Receivable	14.7K	22.5K	6.28K	18.65K	13.42K	18.33K
Days Sales Outstanding	199.42	168.82	38.02	112.64	64.98	146.29
Inventory	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-
Other Current Assets	0	0	20K	59.56K	152.22K	133.9K
Total Non-Current Assets+	1.21M	1.19M	1.16M	1.21M	1.17M	1.3M
Property, Plant & Equipment	48.51K	25.62K	12.64K	3.35K	1.78K	5.5K
Fixed Asset Turnover	0.55x	1.90x	4.77x	18.06x	42.31x	8.31x
Goodwill	0	0	0	0	0	0
Intangible Assets	1.16M	1.17M	1.14M	1.21M	1.17M	1.29M
Long-Term Investments	0	0	0	0	0	0
Other Non-Current Assets	0	0	0	0	0	0
Total Assets+	1.43M	1.29M	1.89M	2.91M	2.46M	2.12M
Asset Turnover	0.02x	0.04x	0.03x	0.02x	0.03x	0.02x
Asset Growth %	-	-0.1%	0.46%	0.54%	-0.16%	-0.14%
Total Current Liabilities+	3.13M	8.38M	7.62M	688.67K	3.19M	1.15M
Accounts Payable	501.03K	859.53K	1.06M	457.56K	760.53K	531.6K
Days Payables Outstanding	2.89K	4.74K	5.59K	2.56K	3.67K	1.5K
Short-Term Debt	515.55K	2.38M	2M	0	1.13M	0
Deferred Revenue (Current)	0	0	0	0	0	0
Other Current Liabilities	2.02M	2M	0	165.95K	768.87K	543.12K
Current Ratio	0.07x	0.01x	0.10x	2.47x	0.40x	0.71x
Quick Ratio	0.07x	0.01x	0.10x	2.47x	0.40x	0.71x
Cash Conversion Cycle	-	-	-	-	-	-
Total Non-Current Liabilities+	0	0	0	0	0	0
Long-Term Debt	0	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	0	0
Deferred Tax Liabilities	0	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	0	0	0
Total Liabilities	3.13M	8.38M	7.62M	688.67K	3.19M	1.15M
Total Debt+	515.55K	2.38M	2M	0	1.13M	0
Net Debt	387.39K	2.36M	1.57M	-1.47M	104.66K	-453.66K
Debt / Equity	-	-	-	-	-	-
Debt / EBITDA	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-
Interest Coverage	-803.46x	-28.69x	-6.20x	-3.69x	-8.02x	-10.30x
Total Equity+	-1.7M	-7.08M	-5.73M	2.23M	-728K	970.06K
Equity Growth %	-	-3.16%	0.19%	1.39%	-1.33%	2.33%
Book Value per Share	-34300.81	-142762.87	-115468.66	52761.77	-11825.83	1028.87
Total Shareholders' Equity	-1.7M	-7.08M	-5.73M	2.23M	-728K	970.06K
Common Stock	68	68	9	5	8	0
Retained Earnings	-20.44M	-25.93M	-31.89M	-39.37M	-44.28M	-51.26M
Treasury Stock	0	0	0	0	0	0
Accumulated OCI	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0

Cash Flow

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-4.17M	-1.79M	-2.35M	-4.95M	-3.65M	-5.27M
Operating CF Margin %	-155.08%	-36.87%	-38.98%	-81.88%	-48.37%	-115.29%
Operating CF Growth %	-	0.57%	-0.31%	-1.11%	0.26%	-0.45%
Net Income	-4.02M	-4.64M	-4.95M	-7.07M	-4.91M	-6.99M
Depreciation & Amortization	178.21K	196.28K	189.37K	143.62K	162.67K	193.14K
Stock-Based Compensation	28.04K	26.13K	0	1.29M	456K	287.45K
Deferred Taxes	0	0	0	0	0	0
Other Non-Cash Items	0	2.08M	1.73M	1.3M	22.88K	1.8M
Working Capital Changes	-358.23K	539.9K	676.29K	-616.1K	622.87K	-564.24K
Change in Receivables	-14.7K	-7.81K	16.22K	-12.29K	-1.49K	7.27K
Change in Inventory	0	0	0	0	0	0
Change in Payables	-249.96K	342.23K	199.6K	-603.1K	220.63K	-156.4K
Cash from Investing+	-267.21K	-179.03K	-152K	-207.87K	-119.52K	-321.94K
Capital Expenditures	-22.36K	-4.74K	-152K	-208.87K	-119.52K	-321.94K
CapEx % of Revenue	0.83%	0.1%	2.52%	3.46%	1.59%	7.04%
Acquisitions	-	-	-	-	-	-
Investments	-	-	-	-	-	-
Other Investing	-244.86K	-174.28K	0	1K	0	0
Cash from Financing+	2.95M	1.86M	2.94M	6.19M	3.31M	5.03M
Debt Issued (Net)	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-
Other Financing	0	0	0	-365.06K	-398.22K	-1.25M
Net Change in Cash	-	-	-	-	-	-
Free Cash Flow+	-4.44M	-1.97M	-2.35M	-5.16M	-3.77M	-5.59M
FCF Margin %	-165.02%	-40.55%	-38.98%	-85.33%	-49.95%	-122.33%
FCF Growth %	-	0.56%	-0.19%	-1.19%	0.27%	-0.49%
FCF per Share	-89452.45	-39760.38	-47360.88	-122259.39	-61183.95	-5932.66
FCF Conversion (FCF/Net Income)	1.04x	0.39x	0.47x	0.70x	0.74x	0.75x
Interest Paid	0	0	0	0	10.71K	13.07K
Taxes Paid	0	0	0	0	0	0

Key Ratios

Metric	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-	-	-317.55%	-655.74%	-5777.8%
Return on Invested Capital (ROIC)	-	-	-	-	-5634.28%	-
Gross Margin	-134.9%	-36.16%	-14.73%	-8.03%	-0.43%	-183.81%
Net Margin	-14943.15%	-9527.35%	-8210.53%	-11694.45%	-6513.41%	-15293.78%
Interest Coverage	-803.46x	-28.69x	-6.20x	-3.69x	-8.02x	-10.30x
FCF Conversion	1.04x	0.39x	0.47x	0.70x	0.74x	0.75x
Revenue Growth	-	80.88%	23.93%	0.25%	24.75%	-39.36%

Frequently Asked Questions

Growth & Financials

Aclarion, Inc. (ACON) reported $0.1M in revenue for fiscal year 2024. This represents a 151% increase from $0.0M in 2019.

Aclarion, Inc. (ACON) saw revenue decline by 39.4% over the past year.

Aclarion, Inc. (ACON) reported a net loss of $7.3M for fiscal year 2024.

Dividend & Returns

Aclarion, Inc. (ACON) has a return on equity (ROE) of -5777.8%. Negative ROE indicates the company is unprofitable.

Aclarion, Inc. (ACON) had negative free cash flow of $6.5M in fiscal year 2024, likely due to heavy capital investments.

← Back to Screener